Price-Driven Insight from (FTRE) for Rule-Based Strategy
Fortrea Holdings Inc. (NASDAQ: FTRE) is showing a mid-channel oscillation pattern with weak near-term sentiment potentially challenging long-term strength. AI models have generated three trading strategies: a Position Trading Strategy (LONG), a Momentum Breakout Strategy (BREAKOUT), and a Risk Hedging Strategy (SHORT). The analysis highlights an exceptional 79.6:1 risk-reward setup, targeting a 23.3% gain versus 0.3% risk.
Wellington Management Group LLP Invests $41.49 Million in Fortrea Holdings Inc. $FTRE
Wellington Management Group LLP has invested $41.49 million in Fortrea Holdings Inc., acquiring 2.38 million shares, representing a 2.51% stake. This investment follows Fortrea's strong Q2 earnings report, where the company surpassed revenue and EPS estimates. Analyst ratings for Fortrea are currently mixed, with an overall "Hold" rating, while the CEO recently sold nearly 100,000 shares to cover tax obligations.
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Unit for $45 Million in Cash
Fortrea Holdings Inc. has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials for $45 million in cash. This acquisition will expand Fortrea's clinical development solutions, enhancing its offerings to pharmaceutical, biotechnology, and medical device customers. The deal was published on September 2, 2026, and is expected to strengthen Fortrea's presence in the life sciences industry.
Fortrea to acquire Worldwide’s early phase unit for $45 million By Investing.com
Fortrea (NASDAQ:FTRE) announced its definitive agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million in cash. This acquisition expands Fortrea's clinical pharmacology services by adding a bioanalytical laboratory and a clinical pharmacology unit, enhancing its North American clinical research footprint. The move allows Worldwide Clinical Trials to focus on its late-stage business.
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Unit for $45 Million in Cash
Fortrea is set to acquire the early phase services unit of Worldwide Clinical Trials for $45 million in cash. The article also briefly mentions Unity Software's fourth-quarter financial results, where revenue increased 35% year-over-year to $609 million, though the company reported a quarterly loss of 66 cents per share.
Fortrea to acquire Worldwide’s early phase unit for $45 million By Investing.com
Fortrea (NASDAQ:FTRE) announced its acquisition of Worldwide Clinical Trials' Early Phase Services division for approximately $45 million in cash. This strategic move includes a bioanalytical laboratory, a clinical pharmacology unit, and a biospecimen storage facility, expanding Fortrea's early clinical development capabilities. The transaction allows Worldwide to focus on its rapidly growing late-stage business.
Bank of America Corp DE Trims Stake in Fortrea Holdings Inc. $FTRE
Bank of America Corp DE significantly reduced its stake in Fortrea Holdings Inc. by 60.7% in the first quarter, selling 455,268 shares and retaining 295,176 shares valued at $2.78 million. Despite mixed analyst sentiment and a "Hold" consensus rating with an average price target of $20.75, Fortrea's latest quarterly results surpassed expectations. CEO Anshul Thakral also sold nearly 100,000 shares to cover tax obligations.
Fortrea COO Mark Morais sells $88,985 in shares after RSU vesting
Fortrea COO Mark Morais sold 4,892 shares of company stock worth $88,985 on August 19, 2026. This non-discretionary sale was executed to cover tax withholding obligations following the vesting of 11,313 Restricted Stock Units (RSUs) on August 18, 2026. Despite the stock being considered slightly overvalued, Fortrea maintains a "GOOD" financial health score and recently provided improved full-year guidance.
Fortrea (FTRE): Buy, Sell, or Hold Post Q2 Earnings?
Despite a recent surge in stock price, Fortrea (FTRE) is advised against as a strong investment. The company exhibits declining revenue, negative return on invested capital (ROIC), and a high forward P/E ratio, suggesting it's overvalued given its fundamentals. Investors are cautioned against the stock and encouraged to look for companies with superior quality standards.
Royal Bank of Canada Has $736,000 Stake in Fortrea Holdings Inc. $FTRE
Royal Bank of Canada significantly reduced its stake in Fortrea Holdings Inc. (NASDAQ:FTRE) by 71.9% in the first quarter, selling 199,618 shares but still holding 78,149 shares valued at approximately $736,000. Despite mixed analyst sentiment with a consensus "Hold" rating, Fortrea's recent quarterly EPS and revenue exceeded estimates. Other institutional investors like Larson Financial Group and Osaic Holdings also adjusted their positions in the company.
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Fortrea Holdings Inc. (FTRE) surpassed Q1 earnings estimates, reporting $0.16 per share against a Zacks Consensus Estimate of $0.03. Despite this, the company's revenues for the quarter missed expectations, and its stock has seen a significant decline year-to-date. The stock currently holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market.
FOHO5602496 Bond Risk Profile
This page provides a risk profile for the Fortrea Holdings Inc. 7.5% 01-JUL-2030 bond, identified as FOHO5602496. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate reliability. The platform offers access to analyst ratings and an in-depth bond breakdown.
Fortrea Holdings COO Mark Morais sells $88,985 in company stock.
Mark A. Morais, COO of Fortrea Holdings Inc., sold company stock valued at $88,985 on August 19, 2026. This transaction was to cover tax obligations related to the vesting of restricted stock units (RSUs), which converted from Labcorp grants following Fortrea's spin-off. After the sale, Morais directly holds 77,786 shares and indirectly holds 4,625 shares through a spouse, in addition to 90,682 derivative securities in RSUs.
Fortrea Holdings COO Mark Morais sells $88,985 in company stock.
Fortrea Holdings COO Mark Morais sold 4,892 shares of company stock worth $88,985. This transaction was not a discretionary trade but was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs). Following these transactions, Morais directly holds 77,786 shares and indirectly holds 4,625 shares through a spouse, in addition to 90,682 derivative securities.
Fortrea Holdings (FTRE) COO has 11,313 RSUs vest
Fortrea Holdings Inc. (FTRE) COO Mark A. Morais had 11,313 Restricted Stock Units (RSUs) vest on August 17, 2026, which were settled into common stock. To cover tax withholding obligations, 4,892 shares were sold at a weighted average price of $18.19. After these transactions, Morais directly holds 90,682 RSUs and his spouse indirectly holds 4,625 common shares.
Fortrea (FTRE) insider plans 4,892-share sale worth 88,975
Fortrea Holdings Inc. officer Mark A. Morais has filed a Rule 144 notice to sell 4,892 shares of common stock, valued at $88,975.21, through Fidelity Brokerage Services LLC. These shares were acquired via restricted stock vesting on August 17, 2026, and the sale includes an amount to cover tax obligations from the vested equity award. The filing also reports two prior sales by Morais in June 2026.
Fortrea Holdings (FTRE) officer lines up $89K stock sale tied to tax on vested shares
Fortrea Holdings Inc. (FTRE) officer Jill G. Mcconnell has filed a notice under Rule 144 for a proposed sale of 4,892 common shares, valued at approximately $88,975.21. This sale is primarily intended to cover tax obligations arising from the settlement of vested equity awards that relate to restricted stock vesting on August 17, 2026. The filing also notes a previous sale of 4,866 shares by Mcconnell in the prior three months, totaling $75,364.61.
Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
Truist Financial has reiterated its Buy rating on Fortrea Holdings (FTRE.US). This indicates a continued positive outlook from the financial institution regarding the company's stock performance.
Precision Trading with Fortrea Holdings Inc. (FTRE) Risk Zones
This article provides an AI-generated analysis for Fortrea Holdings Inc. (FTRE), highlighting divergent sentiment across different time horizons and suggesting choppy conditions. It presents three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones, alongside multi-timeframe signal analysis for near-term, mid-term, and long-term outlooks. The report emphasizes an exceptional risk-reward setup targeting a 24.5% gain versus 0.3% risk.
Precision Trading with Fortrea Holdings Inc. (FTRE) Risk Zones
This article analyzes Fortrea Holdings Inc. (FTRE) using AI models, highlighting a mid-channel oscillation and divergent sentiment across time horizons, suggesting choppy conditions. It presents three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also provides multi-timeframe signal insights, with a strong long-term signal targeting a 24.5% gain.
Assenagon Asset Management S.A. Increases Stake in Fortrea Holdings Inc. $FTRE
Assenagon Asset Management S.A. significantly increased its stake in Fortrea Holdings Inc. by 90.7% in Q2 2026, now owning 173,129 shares valued at $3.0 million. This comes as Fortrea reported strong quarterly results, beating EPS and revenue estimates, while analysts maintain a "Hold" rating with an average price target of $20.75. The article also notes that Fortrea's CEO sold shares to cover tax obligations related to equity awards.
Fortrea (NASDAQ:FTRE) Trading Down 5.4% - Here's What Happened
Fortrea (NASDAQ:FTRE) shares fell 5.4% during midday trading despite beating quarterly earnings and revenue expectations. Analyst sentiment for the stock remains mixed, with a consensus "Hold" rating and an average price target of $20.75. The company's CEO also recently sold nearly 100,000 shares to cover tax obligations.
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Recommendation of "Hold" from Analysts
Analysts have issued a "Hold" consensus recommendation for Fortrea Holdings Inc. (NASDAQ:FTRE), with an average 12-month price target of $20.75. The company recently reported strong quarterly results, exceeding EPS and revenue expectations. CEO Anshul Thakral sold shares to cover tax obligations, and institutional investors have adjusted their holdings.
Fortrea (FTRE) Gains Traction in Turnaround
Curreen Capital, an investment management company, reported in its Q2 2026 investor letter that Fortrea Holdings Inc. (FTRE) is gaining traction in its turnaround efforts. The contract research organization, which spun out of Labcorp in June 2023, closed at $18.99 per share on August 10, 2026, marking a 10.09% year-to-date gain and a 159.78% increase over the past 52 weeks. The firm noted FTRE's attractive upside-to-downside ratio, despite not being among the 40 most popular stocks with hedge funds.
Fortrea (FTRE) Gains Traction in Turnaround
Investment management company Curreen Capital highlighted Fortrea Holdings Inc. (FTRE) in its Q2 2026 investor letter, noting its attractive upside-to-downside ratio. Fortrea, a contract research organization spun out of Labcorp in June 2023, is undergoing a business turnaround and saw a 10.09% year-to-date gain and a 159.78% gain over the past 52 weeks. Although 36 hedge funds held FTRE, Curreen Capital also suggested that certain AI stocks offer greater upside potential with less downside risk.
Ausbil Investment Management Ltd Sells 63,315 Shares of Fortrea Holdings Inc. $FTRE
Ausbil Investment Management Ltd reduced its stake in Fortrea Holdings Inc. (NASDAQ:FTRE) by 21.6%, selling 63,315 shares but retaining 229,826 shares valued at approximately $4.04 million. Fortrea recently reported strong quarterly results, beating analyst estimates with revenue of $678.2 million and earnings of $0.23 per share. Analyst sentiment for FTRE is mixed but generally positive, with an average "Hold" rating and several firms increasing their price targets for the stock.
Fortrea Holdings (FTRE) Beat Expectations, Is The Upside Already Priced In?
Fortrea Holdings (FTRE) exceeded Q2 2026 analyst expectations and raised its full-year guidance, driven by increased biotech demand and improved execution. Despite a significant share price surge over the last year, the stock is considered 6.8% overvalued according to one narrative, while a revenue-based valuation suggests it is undervalued. Investors are encouraged to review the company's risks and rewards to determine if the current price offers sufficient upside.
Dimensional Fund Advisors LP Increases Stake in Fortrea Holdings Inc. $FTRE
Dimensional Fund Advisors LP significantly increased its stake in Fortrea Holdings Inc. (NASDAQ:FTRE) by 163.8% in the first quarter, now owning over 1.29 million shares valued at $12.24 million. Other institutional investors also adjusted their positions in Fortrea, which recently reported better-than-expected quarterly earnings with a revenue of $678.20 million. Despite a recent sale of shares by CEO Anshul Thakral to cover tax obligations, analysts have issued mixed ratings, with a consensus "Hold" and an average price target of $20.75.
Fortrea (FTRE) investor files notice to sell 111,857 shares after vesting
A Fortrea (FTRE) shareholder, Anshul Thakral, has filed a Form 144 notice to sell 111,857 shares of common stock through Fidelity Brokerage Services on NASDAQ. These shares were acquired on August 5, 2026, through restricted stock vesting as compensation, with an aggregate value of over $2 million. The filing also indicates a prior sale of nearly 100,000 shares on the same date.
Securities Lawsuit Alert: Fortrea Holdings Inc. (FTRE) – Contact Levi & Korsinsky Before August 1, 2025
Levi & Korsinsky LLP has filed a class action securities lawsuit against Fortrea Holdings Inc. (NASDAQ:FTRE) on behalf of shareholders who suffered losses due to alleged securities fraud between July 3, 2023, and February 28, 2025. The lawsuit claims that Fortrea made false statements regarding its projected revenue from long-term projects, cost savings, and 2025 EBITDA targets, thus overstating the viability of its post-spin-off business model. Affected shareholders are encouraged to contact the firm to learn about their rights to seek recovery before August 1, 2025.
Fortrea Holdings (NASDAQ: FTRE) CEO settles RSUs and sells 99,869 shares
Fortrea Holdings Inc. CEO Anshul Thakral settled 416,666 Restricted Stock Units (RSUs) on August 4, 2026, and subsequently sold 99,869 shares on August 5, 2026, to cover tax withholding obligations. These sales were mandated "sell to cover" transactions under the company's equity incentive plans and were not discretionary trades. Following these transactions, Thakral still holds 833,334 RSUs, set to vest in three equal annual installments beginning August 4, 2026, and 316,797 shares of common stock.
Levi & Korsinsky Urges Fortrea Holdings Inc. (FTRE) Shareholders to Act Before Lead Plaintiff Deadline August 1, 2025
Levi & Korsinsky LLP is urging shareholders of Fortrea Holdings Inc. (FTRE) who suffered losses between July 3, 2023, and February 28, 2025, to act before the lead plaintiff deadline of August 1, 2025. A class action securities lawsuit has been filed, alleging that Fortrea made false and misleading statements regarding its revenue projections, cost savings, and 2025 EBITDA targets, thus overstating its business and financial prospects. The firm is inviting affected shareholders to learn about their rights to seek recovery with no cost or obligation.
Fortrea Holdings Inc. (FTRE) Gets a Hold from Mizuho Securities
Mizuho Securities analyst Ann Hynes maintained a Hold rating on Fortrea Holdings Inc. (FTRE) with a $19.00 price target, following the company's Q2 earnings report which showed $678.2 million in revenue and a GAAP net loss of $13.2 million. Other analysts have also issued ratings, including a Hold from Deutsche Bank and a Buy from TD Cowen, while corporate insider sentiment is negative due to increased selling activity.
Fortrea Holdings (NASDAQ: FTRE) director sells 9,700 shares at $18.01
Fortrea Holdings Inc. director Machelle Sanders sold 9,700 shares of common stock at $18.01 per share on August 3, 2026. This transaction was not executed under a Rule 10b5-1 trading plan. Following the sale, Machelle Sanders directly holds 36,399 shares of common stock in the company.
Fortrea Holdings Inc. SEC Filing (Aug 5, 2026)
This article reports on Fortrea Holdings Inc.'s Form 144 SEC filing dated August 5, 2026. The filing indicates a proposed sale of 99,869 shares of common stock with an aggregate market value of $1,913,360.21, acquired through restricted stock vesting. The document details the filer and issuer information, the securities to be sold, and confirms no previous sales in the past three months.
Fortrea Holdings (FTRE) awards 15,840 RSUs to interim CFO Smith
Fortrea Holdings Inc. (FTRE) has awarded its interim CFO, Smith David Ross, 15,840 Restricted Stock Units (RSUs). These RSUs will vest in full twelve months after August 3, 2026, provided he continues his service with the company. Following this grant, Smith David Ross now holds an aggregate of 28,692 RSUs in Fortrea.
Fortrea Holdings Inc. Revenue Breakdown – NASDAQ:FTRE
Fortrea Holdings Inc. generated $2.72 billion USD in revenue last year, primarily from its Clinical Services segment. North America was the largest geographical contributor, accounting for $1.29 billion USD. This data indicates a slight increase from the previous year's revenue of $2.70 billion USD.
Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should Know
Fortrea Holdings Inc. (FTRE) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating an upward trend in its earnings estimates. The Zacks rating system, which is based on changes in earnings estimates, suggests that this upgrade reflects positivity about FTRE's earnings outlook, potentially leading to increased stock price and market-beating returns. The company's earnings estimates for fiscal year 2026 have increased by 40.9% over the past three months, further reinforcing its strong buy recommendation.
Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates
Fortrea Holdings Inc. (FTRE) reported Q2 2026 earnings of $0.23 per share, significantly beating the Zacks Consensus Estimate of $0.18, and revenue of $678.2 million, surpassing estimates by 4.62%. Despite mixed estimate revisions, the stock currently holds a Zacks Rank #3 (Hold), indicating expected in-line performance with the market. The company's shares have risen approximately 20% year-to-date, outperforming the S&P 500.
[8-K] Fortrea Holdings Inc. Reports Material Event
Fortrea Holdings Inc. has reported its second-quarter 2026 results, including revenues of $678.2 million and increased full-year guidance for revenue to $2,620 million – $2,690 million and adjusted EBITDA to $205 million – $220 million. The company also announced that David Smith has been appointed interim CFO following Jason Knoblauch's paid leave due to pending litigation, with Smith receiving a substantial RSU grant. This information was detailed in an 8-K filing with the SEC, covering financial performance and significant personnel changes.
Fortrea Holdings Inc. Stock 12‑Month Price Target Raised to $18.9, Implies 9% Downside
Analysts have raised the average 12-month price target for Fortrea Holdings Inc. stock to $18.9, up from $17.8, with individual forecasts ranging from $11 to $25 per share. This new target suggests a potential 9% downside based on the July 28th closing price. The consensus rating from 13 analysts remains "Hold," with an equal split of "Buy" and "Hold" recommendations.
IonQ and Q-CTRL Partner to Unlock Quantum Optimization with Fire Opal on Forte Quantum Processors
Q-CTRL and IonQ have announced the native integration of Q-CTRL's Fire Opal software into IonQ's quantum processors, specifically Forte and Forte-Enterprise devices, to maximize quantum performance for optimization problems. This partnership aims to lower the barriers for users to achieve commercial value from quantum computing by automatically handling execution complexities, eliminating the need for specialized quantum expertise. The integration facilitates solving real-world applications in areas like logistics and finance, as demonstrated by a telecommunications case study where Fire Opal on IonQ Forte optimized network interference from 68 billion possibilities.
What’s Happening With IONQ Stock?
IONQ stock has surged 400% in the last year, reflecting growing interest in quantum computing, despite the technology still being in a developmental stage. The company specializes in trapped-ion quantum computers, offering solutions like IonQ Forte and Aria, and plans to launch Tempo. While quantum computing holds immense promise for various industries, IonQ faces significant financial hurdles, including a small revenue base and operating losses, and its stock has shown high volatility compared to the broader market.
How Integrating Payments Enhances User Engagement, Drives Revenue
Integrating payments into software platforms can significantly enhance user engagement and drive revenue by offering a "one-stop shop" experience with diverse payment options and advanced security. This approach allows software companies to focus on their core competencies while leveraging payment partners for specialized functions like fraud detection and compliance. It also streamlines operations, enables recurring revenue models, and addresses evolving customer expectations for fast and frictionless transactions, despite challenges like varying user tech comfort and the risks associated with instant payments.
CSG Forte 2025: Benefits, Features & Pricing
CSG Forte is a payment management platform designed for businesses of various sizes across multiple industries, handling the entire payment lifecycle from processing to security. It offers omnichannel payment processing supporting ACH, eCheck, credit cards, debit cards, and Apple Pay. The platform emphasizes PCI-compliant architecture, RESTful APIs, and tools for revenue optimization, bill presentment, and reporting.
Forte Acquires N3TWORK’s Platform to Further Accelerate Growth in Blockchain Games
Forte, a leading provider of blockchain solutions for game publishers, has acquired N3TWORK’s technology platform to accelerate its growth in the blockchain gaming industry. The N3TWORK platform team will join Forte, with N3TWORK founder Neil Young leading Forte’s Games Industry business unit. N3TWORK’s games teams will form a new independent company, N3TWORK Studios, which will utilize Forte’s blockchain solutions for its game portfolio.
Advarra Announces Intent to Acquire Forte, Market-Leading Provider of Clinical Technology Solutions
Advarra, a premier provider of IRB and research compliance services, announced its intent to acquire Forte, a leading provider of clinical research technology solutions. This acquisition aims to strengthen Advarra's site-centric solutions portfolio and enhance clinical research by combining eClinical technology with compliance services. The transaction is expected to close in September, supported by Genstar Capital for Advarra and Primus Capital for Forte.
